There has been an increase in the focus of the healthcare industry on chronic and lifestyle diseases such as diabetes and cardiovascular diseases. This has led to an increased demand for targeted medications. Consequently, the Cardiac Diabetic PCD Pharma Franchise model has emerged as a significant business opportunity for entrepreneurs and pharmaceutical professionals.
The pharmaceutical industry in India is highly dynamic and competitive. However, there is greater scope for development in the niche market of cardiac and diabetic care, as the patient population requires extensive healthcare services. In this blog, we will discuss how and why investing in a cardiac diabetic pcd pharma franchise is a beneficial business opportunity.
The Rising Need for Cardiac and Diabetic Care
India is known for having the highest rate of diabetes in the world and one of the highest rates of cardiac related deaths. Studies estimate that over 77 million people with diabetes in India and millions are being newly diagnosed with cardiovascular diseases annually.
This opens up an enormous market for both therapeutic and preventive medicines for diabetes and heart diseases. As with most chronic conditions, the patients need to be put on treatment for life. In this case, the suppliers and franchise owners in this industry have a steady and recurring need for these medicines. This reliable consumer base provides strong and additional layer of stability to the industry.
Specifically in this area, why go for a cardiac diabetic pcd pharma franchise?
PCD or Propaganda-Cum-Distribution model gives an opportunity to small and medium scale pharma distributors to associate and partner with licensed pharma companies to market and sell their drugs under exclusive arrangements. Here’s why it works so smoothly in this segment –
- Specialized Portfolio, High Profit Margins: The portfolio of cardiac and diabetic medicines is a goldmine containing crucial medications as anti-hypertensive, cholesterol regulators, insulin sensitizers, etc. These are mostly expensive, retail and prescription medicines. Franchise holders selling these items have better margins than those selling general medicines.
- Long-Term Customer Retention: Diabetic patients or those diagnosed with cardiovascular problems tend to take these medications for many years and sometimes, a lifetime. Thus, after medical professional green-lights a certain medication, the likelihood of the patient using them is quite high.
- Market Exclusivity Reduces Competition: PCD companies usually grant monopoly rights for a specified territory which protects the franchise partners from competition by that particular company in their region. This is particularly important in the niche cardiac-diabetic care segment as doctors tend to be loyal to particular brands.
- Strong Back-End Support from Pharma Companies: Franchise partners receive high-quality promotional materials, doctor samples, marketing aids and even training resources from reputable pharma companies. This provides an edge to franchisees who are new entrants in the industry, enabling them to penetrate the market more easily.
- Lower Investment, Higher ROI: Compared to full-scale manufacturing units, PCD franchises have minimal start-up expenses, which primarily involve stock procurement and marketing. This investment is dwarfed by the specialized product lines and steady prescriptions from doctors, which yield unprecedented returns.
- Compliance with Quality and Regulations: Franchisees with companies holding WHO-GMP, ISO and DCGI accredited certifications benefit from the goodwill and leverage such franchise partnerships to reduce compliance burdens. This is particularly beneficial in the highly regulated and sensitive cardiac and diabetic categories.
- Expanding Needs in Smaller Cities: The smaller towns and rural areas have begun to adopt chronic disease medications and diagnostics due to the availability of medical infrastructure. This creates new opportunities for franchise owners to expand their reach beyond metropolitan cities.
- Low Operational Complexity: A cardiac diabetic PCD franchise does not require a large team or a complicated distribution network. The business can be easily managed with minimal operations if there is a strong supplier company and good local medical professional contacts.
Who Should Consider This Business Model?
- A stable and scalable business attracts first time pharmaceutical entrepreneurs.
- Self-made entrepreneurs out of medical representatives or pharma sales professionals.
- Distributors seeking to diversify their portfolios with specialized high margin products.
- Regional marketing professionals looking to build their presence in targeted areas.
This business can be extremely profitable if you have, or are willing to create, relationships with doctors, clinics, or other healthcare institutions.
Conclusion
If you are interested in cardiac diabetic pcd pharma franchise, Aplonis Healthcare comes with rich pharmaceuticals expertise & deals in antibiotics, pediatric, gynecology, Dermatologic, Critical Care, General, Ayurveda, etc. We are an ISO 9001:2015 Certified professionally managed Allopathic PCD Pharma Company in India engaged in manufacturing, supplying, trading and distributing quality assured range of Pharmaceutical Medicines (WHO-GMP Certified).
